Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles
Pere Dosta(Brigham and Women's Hospital), Natalie Artzi(Brigham and Women's Hospital), Shiran Ferber(Brigham and Women's Hospital), Tsubasa Shiraishi(Takeda (United States)), Michaela Prado(Brigham and Women's Hospital), Alma L. Rodríguez(Brigham and Women's Hospital), David Lok(Takeda (United States)), Santhosh Kalash(Brigham and Women's Hospital), Walid S. Kamoun(Harvard University), Adnan O. Abu‐Yousif(Takeda (Japan)), Vicky A. Appleman(Takeda (United States)), Tiquella Hatten(Takeda (United States)), Michelle Z. Dion(Brigham and Women's Hospital), Núria Puigmal(Brigham and Women's Hospital), Steven Langston(Millennium Engineering and Integration (United States)), Sean Harrison(Takeda (United States)), Jianing Wang(Hong Kong Baptist University), Michelle L. Ganno(Takeda (United States)), Alexander M. Cryer(Brigham and Women's Hospital), Gonzalo Muñoz Taboada(Institut Químic de Sarrià)
Cited by 149
Related Papers
Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In Situ
|Molecular Cell|2010|461
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
|Nature Medicine|2018|453
Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor
|Nature Chemical Biology|2017|228